This copy is for your personal, non-commercial use only. To order presentation-ready copies for distribution to your colleagues, clients or customers visit http://www.djreprints.com.
Pharma giant Johnson & Johnson reported earnings early Tuesday that beat analyst estimates, sending shares soaring.
Johnson & Johnson (ticker: JNJ) reported sales of $23.3 billion for the third quarter, up 10.7% from the same quarter last year. Adjusted earnings were $2.60 per share, up 18.2% from a year ago.
Analysts had expected slightly…